Radiation-Emitting Products

Mammography Facility Adverse Event and Action Report – October 6, 2017 (Updated October 20, 2017): Allen County Kansas Hospital dba Allen County Regional Hospital

As part of the Mammography Quality Standards Act (MQSA), Congress mandated there be annual reporting of adverse actions taken against mammography facilities. Congress stipulated that the report be made available to physicians and the general public and that it should include information that is useful in evaluating the performance of mammography facilities nationwide. In order to provide this information in the timeliest manner, we now post the following information in “real time,” as actions taken against mammography facilities are concluded:

Mammography Facility Against Which There Was An Adverse Action

The State of Kansas

Facility Name and Address:
Allen County Kansas Hospital dba Allen County Regional Hospital
3066 North Kentucky
Iola, KS 66749

Facility ID Number:

Adverse Event:
On March 28, 2017, The American College of Radiology (ACR) initiated a Full Additional Mammography Review (AMR) of mammograms performed by this facility based on deficiencies noted with the clinical images submitted by the facility during the accreditation renewal process.

The ACR notified the facility on May 16, 2017, that the results of the AMR revealed that fifteen (15) out of thirty (30) clinical cases reviewed failed to meet the ACR’s clinical image evaluation criteria.

Action Taken:
Based on the failed AMR results, on May 22, 2017, the ACR revoked the facility’s accreditation.

After evaluating the reasons for the accreditation revocation, on May 23, 2017, the Food and Drug Administration (FDA) declared the facility’s MQSA certificate to be no longer in effect until such time as the facility’s accreditation is reinstated and the facility has complied with all the requirements of the FDA.

Corrective Action:
Based on the serious image quality deficiencies noted during the AMR, the FDA declared the mammography performed at this facility to be a serious risk to human health and therefore required the facility to perform a Patient and Referring Healthcare Provider Notification (PPN) to alert all at-risk patients and their providers of the mammography quality problems at the facility.

The facility successfully completed the PPN and was notified of such by the FDA on August 11, 2017.

Status of the Facility:
The facility’s accreditation and MQSA certificate were reinstated and the facility is currently performing mammography.

Page Last Updated: 10/20/2017
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English